Logo image
Back
Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming
Journal article   Open access   Peer reviewed

Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming

Raquel Buj, Chi-Wei Chen, Erika S. Dahl, Kelly E. Leon, Rostislav Kuskovsky, Natella Maglakelidze, Maithili Navaratnarajah, Gao Zhang, Mary T. Doan, Helen Jiang, …
Cell reports (Cambridge), v 28(8), pp 1971-1980
20 Aug 2019
DOI: https://doi.org/10.1016/j.celrep.2019.07.084
PMID: 31433975
Featured in Collection :   UN Sustainable Development Goals @ Drexel
url
https://doi.org/10.1016/j.celrep.2019.07.084View
Published, Version of Record (VoR)CC BY-NC-ND V4.0,  Open

Abstract

BRAF cancer metabolism melanoma nevi pentose phosphate pathway ribonucleotide reductase M2 ribose-5-phosphate isomerase A senescence Cell Cycle Pancreatic Cancer
Reprogrammed metabolism and cell cycle dysregulation are two cancer hallmarks. p16 is a cell cycle inhibitor and tumor suppressor that is upregulated during oncogene-induced senescence (OIS). Loss of p16 allows for uninhibited cell cycle progression, bypass of OIS, and tumorigenesis. Whether p16 loss affects pro-tumorigenic metabolism is unclear. We report that suppression of p16 plays a central role in reprogramming metabolism by increasing nucleotide synthesis. This occurs by activation of mTORC1 signaling, which directly mediates increased translation of the mRNA encoding ribose-5-phosphate isomerase A (RPIA), a pentose phosphate pathway enzyme. p16 loss correlates with activation of the mTORC1-RPIA axis in multiple cancer types. Suppression of RPIA inhibits proliferation only in p16-low cells by inducing senescence both in vitro and in vivo. These data reveal the molecular basis whereby p16 loss modulates pro-tumorigenic metabolism through mTORC1-mediated upregulation of nucleotide synthesis and reveals a metabolic vulnerability of p16-null cancer cells. [Display omitted] •p16 knockdown activates mTORC1 to increase nucleotide synthesis and bypass senescence•mTORC1 directly increases translation of RPIA to increase ribose-5-phosphate•Activation of the mTORC1 pathway downstream of p16 suppression is independent of RB•RPIA suppression induces senescence only in cells and tumors with low p16 Senescence bypass through p16 loss predisposes to transformation and tumorigenesis. Buj et al. found that the loss of p16 upregulates nucleotide metabolism through increased mTORC1-mediated translation of RPIA to bypass senescence in an RB-independent manner. Thus, the mTORC1-RPIA axis is a metabolic vulnerability for p16-null cancers.

Metrics

14 Record Views
49 citations in Web of Science
44 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Cell Biology
Logo image